Effect of Right Ventricular Lead Position on Defibrillation Threshold
Withdrawn before enrolling · Not applicable
Conditions studied: Ventricular Tachycardia, Ventricular Fibrillation
In brief
The purpose of this study is to determine how the position of the right ventricular (RV) coil of an implantable cardioverter defibrillator (apex versus septum) affects the defibrillation threshold; specifically, can defibrillator threshold be improved by implantation site selection.
Key facts
- Study ID
- NCT02844127
- Run by
- OhioHealth
- People needed
- 0
- Starts
- 2016-11-01
- Expected to finish
- 2017-04-04
- Last updated by the study team
- 2017-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient indicates for single-chamber (VR), dual-chamber (DR) or resynchronization CRT-D) implantable defibrillator
- Left-sided implant
- Single coil or dual coil (single coil for testing)
- Age ≥ 18 years of age
- Ability to consent
- Medically stable, in the opinion of the implanting physician, to undergo defibrillation safety margin testing
- Procedure performed under conscious sedation
- English-speaking
You may not qualify if…
- Patient unable to understand and consent to the procedure on his or her own
- Pregnant or breastfeeding patients
- New York Heart Association (NYHA) Class IV
- Patients with pre-existing RV leads
- Pacemaker dependent
- Patient medically unstable to undergo defibrillation testing (e.g., high risk for deep sedation; patients that develop respiratory compromise or hemodynamic instability from the sedation)
- Patients that require general anesthesia instead of conscious sedation
- Patients <18 years of age
- Non-English-speaking
Where it is running
- OhioHealth Grant Medical Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.